diaziquone has been researched along with Bone Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartolucci, A; Brenner, D; Carpenter, J; Chan, C; Clamon, G; Davila, E; Greco, FA; Moore, J; Presant, C | 1 |
| Baker, LH; Balcerzak, SP; Rivkin, SE; Stephens, RL; Zidar, BL | 1 |
2 other study(ies) available for diaziquone and Bone Cancer
| Article | Year |
|---|---|
Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: a Southeastern Cancer Study Group Trial.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Bone Neoplasms; Drug Evaluation; Drug Resistance; Female; Humans; Male; Middle Aged; Naphthacenes; Sarcoma; Soft Tissue Neoplasms | 1986 |
Phase II study of diaziquone in advanced soft tissue and bony sarcoma: a Southwest Oncology Group study.
Topics: Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Bone Neoplasms; Drug Evaluation; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Sarcoma; Soft Tissue Neoplasms | 1985 |